Peter Rothschild, President of BioGaia, summarizes the first quarter of 2014 and answers to questions regarding;
- the new extensive agreement with Nestlé,
- the development of salen in the US market,
- upcoming events in the BRIC countries,
- how the situation in Ukraine and Russia affect the sales,
- and how the company is affected by the published study showing a neutral effect of L. reuteri Protectis in reducing colic.